Efficacy of Polygonatum Sibiricum on Sleep Quality Improvement
NCT ID: NCT03337789
Last Updated: 2018-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2016-11-07
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study to Assess a Dietary Supplement on Sleep Health and Quality
NCT05368909
Impact of Nutritional Supplementation on Sleep Quality and Gut Microbiome Composition in Older Adults
NCT04078724
Ciwujia Capsules/Compound Ciwujia Granules in the Treatment of Insomnia
NCT07286838
Clinical Study to Investigate the Sleep Quality Enhancing Effect of GABA
NCT04857021
Effect of Bacopa Monnieri on Working Memory and Cognitive Processing in Student
NCT02931747
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Polygonatum sibiricum
Polygonatum sibiricum
Polygonatum sibiricum 800mg, 30-60 minutes before sleep, once a day for 4 weeks
Placebo
Placebo
Placebo 800mg, 30-60 minutes before sleep, once a day for 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polygonatum sibiricum
Polygonatum sibiricum 800mg, 30-60 minutes before sleep, once a day for 4 weeks
Placebo
Placebo 800mg, 30-60 minutes before sleep, once a day for 4 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experienced any of the following sleep problems, at least more than once a week for more than 2 months: 1) difficulty in falling asleep or staying asleep; 2) waking up at dusk and not being able to fall asleep again; 3) not feeling refreshed even after getting some sleep.
Exclusion Criteria
* Possibility of drug-induced sleep disorders due to current intake of medication (i.e., corticosteroid, statin, etc)
* Had taken sleeping pills (i.e., zolpidem, benzodiazepine) during the past 2 months
* Diagnosed with any major medical or neurological disorders assessed during medical history taking, physical examination or experimental tests.
* Diagnosed with any axis 1 psychiatric disorders (depressive disorder, bipolar disorder, alcohol dependence, schizophrenia) evaluated with a structured instrument
* A history of traumatic brain injury with loss of consciousness, or any contraindications to MRI (i.e., claustrophobia, metallic foreign devices in body)
* Had taken psychotropic drugs within the past 3 months before study participation
* Allergic to polygonatum sibiricum or experienced side effects after consumption of any product containing polygonatum sibiricum
* Participated in another clinical trial or took other medications during the period that may influence the results of this clinical trial
* Currently taking contraceptive pills
* Planning for pregnancy during the period of study participation, currently pregnant or breastfeeding
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ewha Womans University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jieun Kim
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ewha Womans University
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.